216 related articles for article (PubMed ID: 31751140)
1. Structure-Activity Relationship Studies of Pyridine-Based Ligands and Identification of a Fluorinated Derivative for Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors.
Haider A; Kretz J; Gobbi L; Ahmed H; Atz K; Bürkler M; Bartelmus C; Fingerle J; Guba W; Ullmer C; Honer M; Knuesel I; Weber M; Brink A; Herde AM; Keller C; Schibli R; Mu L; Grether U; Ametamey SM
J Med Chem; 2019 Dec; 62(24):11165-11181. PubMed ID: 31751140
[TBL] [Abstract][Full Text] [Related]
2. Identification and Preclinical Development of a 2,5,6-Trisubstituted Fluorinated Pyridine Derivative as a Radioligand for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors.
Haider A; Gobbi L; Kretz J; Ullmer C; Brink A; Honer M; Woltering TJ; Muri D; Iding H; Bürkler M; Binder M; Bartelmus C; Knuesel I; Pacher P; Herde AM; Spinelli F; Ahmed H; Atz K; Keller C; Weber M; Schibli R; Mu L; Grether U; Ametamey SM
J Med Chem; 2020 Sep; 63(18):10287-10306. PubMed ID: 32787079
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2.
Slavik R; Müller Herde A; Haider A; Krämer SD; Weber M; Schibli R; Ametamey SM; Mu L
J Neurochem; 2016 Sep; 138(6):874-86. PubMed ID: 27385045
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of 4-oxo-quinoline-based CB2 PET radioligands in R6/2 chorea huntington mouse model and human ALS spinal cord tissue.
Haider A; Spinelli F; Herde AM; Mu B; Keller C; Margelisch M; Weber M; Schibli R; Mu L; Ametamey SM
Eur J Med Chem; 2018 Feb; 145():746-759. PubMed ID: 29353725
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Preclinical Evaluation of Fluorinated 5-Azaindoles as CB2 PET Radioligands.
Kallinen A; Mardon K; Lane S; Montgomery AP; Bhalla R; Stimson DHR; Ahamed M; Cowin GJ; Hibbs D; Werry EL; Fulton R; Connor M; Kassiou M
ACS Chem Neurosci; 2023 Aug; 14(16):2902-2921. PubMed ID: 37499194
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of [
Haider A; Wang L; Gobbi L; Li Y; Chaudhary A; Zhou X; Chen J; Zhao C; Rong J; Xiao Z; Hou L; Elghazawy NH; Sippl W; Davenport AT; Daunais JB; Ahmed H; Crowe R; Honer M; Rominger A; Grether U; Liang SH; Ametamey SM
ACS Chem Neurosci; 2023 Oct; 14(20):3752-3760. PubMed ID: 37788055
[TBL] [Abstract][Full Text] [Related]
7. Development of a High-Affinity PET Radioligand for Imaging Cannabinoid Subtype 2 Receptor.
Moldovan RP; Teodoro R; Gao Y; Deuther-Conrad W; Kranz M; Wang Y; Kuwabara H; Nakano M; Valentine H; Fischer S; Pomper MG; Wong DF; Dannals RF; Brust P; Horti AG
J Med Chem; 2016 Sep; 59(17):7840-55. PubMed ID: 27500461
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and preliminary evaluation of [18F]-labeled 2-oxoquinoline derivatives for PET imaging of cannabinoid CB2 receptor.
Turkman N; Shavrin A; Paolillo V; Yeh HH; Flores L; Soghomonian S; Rabinovich B; Volgin A; Gelovani J; Alauddin M
Nucl Med Biol; 2012 May; 39(4):593-600. PubMed ID: 22226022
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and preliminary evaluation of a new fluorine-18 labelled triazine derivative for PET imaging of cannabinoid CB2 receptor.
Hortala L; Arnaud J; Roux P; Oustric D; Boulu L; Oury-Donat F; Avenet P; Rooney T; Alagille D; Barret O; Tamagnan G; Barth F
Bioorg Med Chem Lett; 2014 Jan; 24(1):283-7. PubMed ID: 24291040
[TBL] [Abstract][Full Text] [Related]
10. Radiolabeling and in vitro /in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor.
Mu L; Bieri D; Slavik R; Drandarov K; Müller A; Cermak S; Weber M; Schibli R; Krämer SD; Ametamey SM
J Neurochem; 2013 Sep; 126(5):616-24. PubMed ID: 23795580
[TBL] [Abstract][Full Text] [Related]
11. Preclinical evaluation of [
Attili B; Celen S; Ahamed M; Koole M; Haute CVD; Vanduffel W; Bormans G
Br J Pharmacol; 2019 May; 176(10):1481-1491. PubMed ID: 30588600
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and preliminary evaluation of (18)F-labelled 1,8-naphthyridin- and quinolin-2-one-3-carboxamide derivatives for PET imaging of CB2 cannabinoid receptor.
Saccomanni G; Pascali G; Carlo SD; Panetta D; De Simone M; Bertini S; Burchielli S; Digiacomo M; Macchia M; Manera C; Salvadori PA
Bioorg Med Chem Lett; 2015 Jun; 25(12):2532-5. PubMed ID: 25956416
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, radiolabeling and evaluation of novel 4-oxo-quinoline derivatives as PET tracers for imaging cannabinoid type 2 receptor.
Slavik R; Herde AM; Bieri D; Weber M; Schibli R; Krämer SD; Ametamey SM; Mu L
Eur J Med Chem; 2015 Mar; 92():554-64. PubMed ID: 25599952
[TBL] [Abstract][Full Text] [Related]
14. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
[TBL] [Abstract][Full Text] [Related]
15. Development of [
Teodoro R; Gündel D; Deuther-Conrad W; Ueberham L; Toussaint M; Bormans G; Brust P; Moldovan RP
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360817
[TBL] [Abstract][Full Text] [Related]
16. Radiosynthesis and Biological Investigation of a Novel Fluorine-18 Labeled Benzoimidazotriazine- Based Radioligand for the Imaging of Phosphodiesterase 2A with Positron Emission Tomography.
Ritawidya R; Wenzel B; Teodoro R; Toussaint M; Kranz M; Deuther-Conrad W; Dukic-Stefanovic S; Ludwig FA; Scheunemann M; Brust P
Molecules; 2019 Nov; 24(22):. PubMed ID: 31731831
[TBL] [Abstract][Full Text] [Related]
17. Design, Radiosynthesis and Preliminary Biological Evaluation in Mice of a Brain-Penetrant
Moldovan RP; Gündel D; Teodoro R; Ludwig FA; Fischer S; Toussaint M; Schepmann D; Wünsch B; Brust P; Deuther-Conrad W
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34064122
[TBL] [Abstract][Full Text] [Related]
18. Structure-Based Design, Optimization, and Development of [
Gündel D; Deuther-Conrad W; Ueberham L; Kaur S; Otikova E; Teodoro R; Toussaint M; Lai TH; Clauß O; Scheunemann M; Bormans G; Bachmann M; Kopka K; Brust P; Moldovan RP
J Med Chem; 2022 Jul; 65(13):9034-9049. PubMed ID: 35771668
[TBL] [Abstract][Full Text] [Related]
19. Preclinical Development of
Ahmed H; Wallimann R; Haider A; Hosseini V; Gruber S; Robledo M; Nguyen TAN; Herde AM; Iten I; Keller C; Vogel V; Schibli R; Wünsch B; Mu L; Ametamey SM
J Nucl Med; 2021 Feb; 62(2):259-265. PubMed ID: 32737247
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a high affinity and selective pyridine analog as a potential positron emission tomography imaging agent for cannabinoid type 2 receptor.
Slavik R; Grether U; Müller Herde A; Gobbi L; Fingerle J; Ullmer C; Krämer SD; Schibli R; Mu L; Ametamey SM
J Med Chem; 2015 May; 58(10):4266-77. PubMed ID: 25950914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
